Turkish Validation Study of Endometriosis Health Profile -30 (EHP-30) Test
Overview
For the Turkish validation Study of the Endometriosis Health Profile test (EHP-30) consisting of 30 questions, this 30-question test will be applied to 228 patients after 2 different translations to be applied after the translation of this 30-question test sworn translator to the patients who have been surgically diagnosed with endometriosis.
Full Title of Study: “Turkish Validation of Endometriosis Health Profile -30 (EHP-30) Test”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 20, 2021
Detailed Description
The appointment of the patients consists of patients who were surgically diagnosed with Endometriosis in our clinic. English and Turkish translation will be verified after 2 different sworn translators.
Interventions
- Other: Endo Patients with Endometriosis Health Profile -30 (EHP-30) Test
- The appointment of the patients consists of patients who were surgically diagnosed with Endometriosis in our clinic.
Clinical Trial Outcome Measures
Primary Measures
- Turkish Validation of Endometriosis Health Profile -30 (EHP-30) Test
- Time Frame: 3 months
- The Turkish validation study of the Endometriosis Health Profile -30EHP-30 test, which shows the general quality of life of endometriosis patients, will be performed and the use of Turkish language will be provided.
Participating in This Clinical Trial
Inclusion Criteria
- being surgically diagnosed with endometriosis – Age between 18- 45 – not being pregnant Exclusion Criteria:
- have been diagnosed with endometriosis by ultrasound – above 45 and under 18 years old – use psichiatrig drugs – being diagnosed with a psychiatric illness
Gender Eligibility: Female
Women with Endometriosis(surgicallay diagnosed)
Minimum Age: 18 Years
Maximum Age: 45 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
- Collaborator
- Engin Oral
- Provider of Information About this Clinical Study
- Principal Investigator: Pınar Yalcin bahat, Principal Investigator – Kanuni Sultan Suleyman Training and Research Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.